Becker's Healthcare March 7, 2024
Mackenzie Bean

An FDA advisory panel has unanimously recommended the agency approve a trivalent, rather than quadrivalent, flu vaccine for use next season.

The FDA’s Vaccines and Related Biological Products Advisory Committee urged manufacturers to remove the influenza B Yamagata lineage strain from next season’s flu shots during a March 5 meeting. The flu type B lineage hasn’t been detected globally since March 2020 and no longer poses...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
HHS Explores Stronger FDA Oversight for Food Ingredients
HHS Secretary Kennedy Directs FDA to Explore Rulemaking to Eliminate Self-Affirmed GRAS Pathway

Share This Article